-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Albemarle delivered strong Q1 results with net sales of $1.43B (+33% Y/Y, 8.4% above consensus) and adjusted EPS of $2.95 vs. a loss of $0.18 in the prior year, beating consensus by $1.64. Adjusted EBITDA surged 148% Y/Y to $664M, demonstrating significant operational leverage as lithium pricing recovered. The Energy Storage segment led recovery with sales of $891M (+70% Y/Y) driven by pricing improvements (+51%) and volume growth (+14%), while adjusted EBITDA jumped 196% to $551M. Management provided 2026 outlook scenarios based on lithium pricing. Assuming the FY 25 average (~$10/kg LCE) projects $4.1B-$4.3B sales and $0.9B-$1.0B adjusted EBITDA, while the Q1 2026 average (~$20/kg LCE) suggests $5.7B-$6.0B sales and $2.4B-$2.6B adjusted EBITDA. We believe ALB's balance sheet optimization through $1.3B debt reduction and $648M in divestiture proceeds strengthens financial flexibility. ALB remains on track for $100M-$150M in annual cost improvements while maintaining disciplined capex guidance of $550M-$600M.